Hem › Bröstcancer › Colorado › Denver
Kliniska studier för Bröstcancer i Denver, CO
29 studier för Bröstcancer söker deltagare vid platser i och runt Denver (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekryterarFriska volontärer välkomna
- Kaiser Permanente-Franklin, Denver
A Study of PHST001 in Advanced Solid Tumors
RekryterarFas 1
- Sarah Cannon Research Institute (SCRI) Oncology Partners - Denver Health One, Denver
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekryterarFas 1/2
- Rocky Mountain Cancer Center, Denver
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekryterarFas 3
- Rocky Mountain Cancer Centers, Denver
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- AdventHealth Porter, Denver
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
RekryterarFas 2
- Rocky Mountain Cancer Centers, Denver
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
RekryterarFas 1
- Sarah Cannon Research Institute (Scri) At Health One, Denver
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RekryterarFas 3
- UCHealth Cherry Creek Medical Center ( Site 0094), Denver
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekryterarFas 3
- Research Site, Denver
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RekryterarFas 3
- UCHealth Cherry Creek Medical Center, Denver
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RekryterarFas 2
- Saint Joseph Hospital - Cancer Centers of Colorado, Denver
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekryterarFas 3
- Intermountain Health Cancer Center Saint Joseph ( Site 0062), Denver
- Rocky Mountain Cancer Centers (RMCC) ( Site 8006), Denver
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekryterarFas 3
- Clinical Trial Site, Denver
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekryterarFas 3
- St. Joseph Hospital-Cancer Centers of Colorado, Denver
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
RekryterarFas 1/2
- Skin Cancer Institute, Englewood · 6 mi bort
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekryterarFas 3
- UCHealth - Cherry Creek, Denver
- Saint Joseph Hospital - Cancer Centers of Colorado, Denver
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RekryterarFas 1
- Sarah Cannon Research Institute at HealthONE, Denver
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RekryterarFas 1
- Sarah Cannon Research Institute - Denver DDU, Denver
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
RekryterarFas 1
- Sarah Cannon Research Institute (SCRI) at HealthONE-Denver, Denver
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
RekryterarFas 2/3
- Rocky Mountain Cancer Centers, Denver
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekryterarFas 3
- Rocky Mountain Cancer Centers, Denver
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RekryterarFas 1/2
- Sarah Cannon Research Institute, Denver
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekryterarFas 3
- Rocky Mountain Cancer Centers LLP, Denver
- Rocky Mountain Cancer Centers LLP, Englewood · 6 mi bort
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekryterarFas 3
- UCHealth - Cherry Creek, Denver
- Rose Medical Center, Denver
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekryterarObservationsstudie
- Kaiser Permanente-Franklin, Denver
- Colorado Blood Cancer Institute, Denver
- Rocky Mountain Cancer Centers-Midtown, Denver
- och 1 fler
The Immune System's Response to Young Women's Breast Cancer
RekryterarObservationsstudie
- Denver Health Hospital Authority, Denver
- UCHealth Cherry Creek Medcial Center, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Denver
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
RekryterarFas 1
- HealthONE, Denver
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RekryterarObservationsstudie
- Comprehensive Breast Care of Denver, Denver
Bröstcancer-studier i andra städer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andra studier i Denver
- Metastaserande cancer29 studier
- Icke-småcellig lungcancer27 studier
- Multipelt myelom27 studier
- Kolorektal cancer23 studier
- Melanom19 studier
- Prostatacancer19 studier
- Cancer (alla typer)18 studier
- Äggstockscancer16 studier
- Lungcancer16 studier
- Endometriecancer15 studier
- Non-Hodgkins lymfom14 studier
- Bukspottkörtelcancer13 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.